Recombinant primate granulocyte macrophage-colony stimulating factor
Patent Number: 5942221
Date of First Priority Issue: Wednesday July 6th, 1994
Date Issued: Tuesday August 24th, 1999
Assignee: Novartis Corporation (Basel, CH)
Inventors: Clark, Steven C. (Winchester, MA); Kaufman, Randal J. (Boston, MA); Wong, Gordon G. (Cambridge, MA)
This patent covers primate G-CSF. G-CSF is a potent stimulator of granulocyte production and is used clinically under the name Neupogen and more recently Neulasta.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking: